Doyle Thomas Jamesinsider trades
In SEC Form 4 filings, Doyle Thomas James is listed as SVP, Finance & Accounting of Kura Oncology, Inc. (KURA). In the last 90 days, Doyle Thomas James sold $48.4K of Kura Oncology, Inc. (KURA) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| KURAKura Oncology, Inc. | SVP, Finance & Accounting | 1 | Sep 29 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-29
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.